Welcome to Advances in Clinical and Experimental Medicine, an esteemed publication by WROCLAW MEDICAL UNIVERSITY, dedicated to advancing the essential fields of clinical and experimental medicine. With an open access model since 2017, this journal ensures that researchers, healthcare professionals, and students worldwide can freely access high-quality scientific content. Covering a broad spectrum of topics including biochemistry, genetics, internal medicine, and pharmacology, Advances in Clinical and Experimental Medicine has established itself as a pivotal resource in the scientific community, currently holding prestigious rankings such as Q2 in Biochemistry, Genetics, and Molecular Biology (miscellaneous) and Q1 in Reviews and References (medical) for 2023. Spanning over two decades of rigorous research publication, the journal is a critical platform for sharing innovative findings and fostering collaboration among scholars, making it an invaluable asset for those at the forefront of medical science.

The Journal of Istanbul Faculty of Medicine (Istanbul Tip Fakultesi Dergisi), published by ISTANBUL UNIVERSITY, FACULTY OF MEDICINE, is an esteemed open-access journal that has been committed to disseminating significant medical research since becoming open access in 2017. As a platform for transformative scholarly work, this journal is situated in Turkey and actively engages with diverse medical disciplines to contribute to the collective understanding of health and medicine. Featuring a range of studies that span various facets of medical science, the journal is categorized within the Q4 quartile in Medicine (miscellaneous) for 2023, with its Scopus rankings placing it at #586 out of 636 in the General Medicine category, marking it as a resource that is gaining traction within the academic community. This journal aims to serve as a vital resource for researchers, healthcare professionals, and students alike, fostering the exchange of ideas and innovation in medicine. By providing public access to its content, it underscores the importance of open science in enhancing knowledge sharing and collaboration across borders. For those interested in advancing their research and professional development, the Journal of Istanbul Faculty of Medicine is an invaluable tool for staying informed on the latest findings and discussions in the medical field.

The American Journal of Translational Research is a pivotal publication in the fields of Biochemistry, Genetics, and Molecular Biology, dedicated to advancing the understanding of translational science and its applications in clinical settings. Published by E-CENTURY PUBLISHING CORP, this journal, under ISSN 1943-8141, fosters scholarly exchange by publishing original research articles, reviews, and clinical studies that bridge the gap between laboratory discoveries and actual medical practice. Although its coverage in Scopus has been discontinued, the journal has previously held respectable rankings, including a 64th percentile in Clinical Biochemistry and 52nd in both Molecular Medicine and Cancer Research, indicating its influence and relevance in the scientific community. With its formal objective of disseminating significant findings that inform clinical practices, the journal remains a valuable resource for researchers, healthcare professionals, and students eager to stay at the forefront of translational research advancements.

Byulleten Sibirskoy Meditsiny, published by the Siberian State Medical University, is a pivotal open-access journal in the field of Molecular Medicine, with its current edition indexed under the ISSN 1682-0363. Since its transition to open access in 2013, the journal aims to disseminate high-quality research and advancements in biomedical sciences, particularly focusing on molecular mechanisms and therapeutic interventions. Despite its relatively recent recognition in Molecular Medicine, where it ranks in the 6th percentile, the journal is dedicated to fostering knowledge exchange and collaboration among researchers, professionals, and students alike. With a modest impact factor and quarterly publication, Byulleten Sibirskoy Meditsiny is positioned to serve as a valuable resource for those engaged in the intricate realms of molecular biology, biochemistry, and general medicine, contributing to the broader scientific discourse in the Russian Federation and beyond.

Biomed Research International is a prominent open access journal published by HINDAWI LTD, dedicated to advancing the field of biomedical research. With its ISSN 2314-6133 and E-ISSN 2314-6141, this journal has been a significant contributor to the scientific community since its inception in 2013, making scholarly work accessible to a global audience. The journal's scope encompasses a range of disciplines, including biochemistry, genetics, molecular biology, immunology, microbiology, and medicine, reflecting its commitment to interdisciplinary research. Ranked in the Q2 quartile as of 2023 across several relevant categories, Biomed Research International is recognized for its high-quality publications that foster innovation and collaboration in biomedical studies. Researchers, professionals, and students looking to share and gain insights into cutting-edge biomedical discoveries will find this journal an essential resource. With a focus on rapid dissemination of research findings, the journal serves as a vital platform for academics to engage with contemporary issues in health and disease, ultimately contributing to the advancement of medical science.

Nature Protocols, published by NATURE PORTFOLIO, is a premier academic journal specializing in the dissemination of innovative and practical experimental methodologies in the vast field of biochemistry, genetics, and molecular biology. With an impressive Scopus rank of #5 out of 221 journals and a 97th percentile status, it stands firmly in the Q1 quartile, reflecting its integral role in advancing scientific knowledge. Established in 2006, this journal provides an invaluable resource for researchers and practitioners aiming to refine their experimental techniques, ultimately driving forward the frontiers of life sciences. While currently operating under a subscription model, the journal continues to be a pivotal platform for sharing high-quality, peer-reviewed protocols that facilitate reproducibility and transparency in research. Addressing a global audience from its base in the United Kingdom, Nature Protocols is dedicated to fostering collaboration and innovation, making it indispensable for professionals and students engaged in cutting-edge scientific endeavors.

BIOMEDICAL PAPERS-OLOMOUC, published by Palacky University Medical Faculty, is a prominent open-access journal dedicated to advancing the fields of biochemistry, genetics, molecular biology, and general medicine. Since its inception in 2001, this journal has provided a vital platform for researchers, professionals, and students alike, fostering a collaborative environment for the dissemination of cutting-edge research findings. With a current impact factor reflected in its placement in the Q3 quartiles for both biochemistry and medicine categories, it demonstrates a growing influence in the academic community. The journal is indexed in Scopus, showcasing its relevance within the medical and biophysical sciences, and it operates in an open-access format to ensure broad accessibility of its articles. Set against the backdrop of Olomouc, Czech Republic, BIOMEDICAL PAPERS-OLOMOUC continues to contribute significantly to the global dialogue in biomedical research, making it an essential resource for anyone engaged in these dynamic and rapidly evolving fields.

Biomedica is a distinguished journal published by the Instituto Nacional de Salud in Colombia, dedicated to advancing knowledge within the fields of biochemistry, genetics, molecular biology, and general medicine. Since its inception in 1981, this Open Access journal has embodied a commitment to disseminating high-quality research, ensuring free and universal access to its published works. With an impressive Scopus Ranking—273rd out of 636 in Medicine and 148th out of 221 in Biochemistry, Genetics and Molecular Biology—Biomedica holds a Q3 category in both disciplines as of 2023, reflecting its growing impact and relevance in the scientific community. The journal welcomes contributions that further our understanding and lead to advancements in healthcare and biological sciences, serving as a critical resource for researchers, professionals, and students alike. The journal operates within a continuous publication model from 2001 to 2024, enriching the academic landscape with contemporary findings and fostering collaboration within the biomedical field.

Yale Journal of Biology and Medicine, established in 1945, is a distinguished peer-reviewed academic journal published by Yale J Biology Medicine, Inc. This journal serves as an essential platform for the dissemination of high-quality research in the fields of biochemistry, genetics, molecular biology, and medicine. With a notable impact factor and ranking in the top quartiles (Q2) of both biochemistry and medicine categories according to the latest metrics, it underscores its relevance and influence in the academic community. Committed to advancing understanding in these dynamic fields, the journal encourages submissions that contribute to both fundamental and applied scientific knowledge. Although it does not currently follow an open access model, the journal remains highly accessible through various academic databases. Researchers, professionals, and students are invited to explore cutting-edge findings and innovative perspectives that continue to shape the landscape of biology and medicine.

Journal of Biomedical Research, published by Nanjing Medical University in China, is a prominent platform for groundbreaking discoveries in the fields of Biochemistry, Genetics, and Molecular Biology, as well as Medicine. With an ISSN of 1674-8301 and an E-ISSN of 1876-4819, the journal offers a vital opportunity for researchers, professionals, and students to disseminate insightful research findings. Although not currently available as an open access journal, its inclusion in the second quartile of both Biochemistry and Medicine categories underscores its growing influence and commitment to high-quality scholarship, as evidenced by its historical compliance with Scopus rankings prior to 2009. By fostering an interdisciplinary approach, the Journal of Biomedical Research aims to bridge gaps in current biomedical understanding and encourages innovative research that can lead to significant contributions in improving health outcomes. Its editorial policies guarantee rigorous peer review, making it a trusted source of knowledge in the biomedical community.